ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,886.65
      -0.04%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Autolus Therapeutics PLC (AUTL)

      7. Autolus Therapeutics PLC (AUTL) Financials

      Autolus Therapeutics PLC

      Autolus Therapeutics PLC (AUTL)

      NASDAQ
      4.67
      0.07
      (1.52%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      4.67
      0.005
      (0.11%)
      After Hours: 6:00PM
      Delayed by 15 minutes

      Autolus Therapeutics PLC Financial Summary

      The current AUTL market cap is 1.24B. The company's latest EPS is USD -0.7833 and P/E is -5.95.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.07M482k-858k010.09M
      Operating Income -38.55M-47.38M-49.09M-40.89M-40.36M
      Net Income -39.81M-45.55M-45.85M-77.17M-52.69M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.91M1.72M2.33M6.36M1.7M
      Operating Income -146.06M-168.15M-163.65M-138.9M-183.51M
      Net Income -123.85M-142.09M-142.1M-148.84M-208.38M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 459.97M450.99M406.1M375.38M901.44M
      Total Liabilities 193.05M221.66M225.58M263.91M319.41M
      Total Equity 266.92M229.34M180.52M111.47M582.03M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 303.53M294.24M405.56M490.27M375.38M
      Total Liabilities 48.69M84.21M92.24M191.6M263.91M
      Total Equity 254.84M210.03M313.32M298.67M111.47M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -42.42M-80.57M-120.75M N/A -40.51M
      Investing -3.62M-8.01M-9.51M N/A -533k
      Financing -691k-910k-906k N/A 561.44M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -101.48M-117.76M-117.86M-112.31M-145.59M
      Investing -18.67M-14.68M-8.86M-10.84M-10.99M
      Financing 108.86M74.42M284.06M223.61M-883k

      Stats and Ratios

      Market Cap 1.24B
      Price to Earnings Ratio -5.95
      Price to Sales Ratio 728.13
      Price to Cash Ratio 5.17
      Price to Book Ratio 11.12
      Dividend Yield -

      Share Statistics

      Shares Outstanding 266.04M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.59 (11.92%)

      Company Info

      Company Name Autolus Therapeutics PLC
      Address 191 wood lane
      london W12 7FP
      Website https://www.autolus.com
      Industry pharmaceutical preparations (2834)